- €3.21bn
- €3.68bn
- $1.24bn
- 61
- 85
- 88
- 93
C2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 915 | 1,210 | 420 | 855 | 1,235 |
Cost of Revenue | |||||
Gross Profit | 552 | 867 | 80.3 | 463 | 862 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 719 | 676 | 701 | 560 | 265 |
Operating Profit | 196 | 534 | -282 | 294 | 970 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 113 | 475 | -339 | 206 | 864 |
Provision for Income Taxes | |||||
Net Income After Taxes | 112 | 473 | -339 | 203 | 858 |
Net Income Before Extraordinary Items | |||||
Net Income | 112 | 473 | -339 | 203 | 858 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 112 | 473 | -339 | 203 | 858 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.451 | 2.14 | -1.73 | 0.539 | 2.42 |
Dividends per Share |